Reconsidering biologic treatment recommendations for CRSwNP without asthma in EUFOREA guidelines
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
The recently published EUFOREA pocket guide "Biologics in Upper and Lower Airway Diseases" summarises recommendations on the use of biologics in chronic rhinosinusitis with nasal polyps (CRSwNP) and asthma and offers advice on biologic choice for practicing clinicians. The creation of this pocket guide, in the absence of any head-to-head studies at that time, drew on expert opinions and published indirect treatment comparison (ITC) approaches. It makes a single recommendation for a preferred biologic, in patients affected by CRSwNP, without concomitant asthma (apart from specific cases such as pregnancy), whilst offering different options in asthma endotypes and phenotypes. We wish to draw the attention of the readership to some additional considerations relating to biologic choice for these diseases and how they are classified.
Fields of Study & Subjects
Sinusitis and nasal conditions
Cystic Fibrosis Research Advances
Asthma and respiratory diseases
Publication details
- Journal / source
- Rhinology Journal
- Volume
- 0
- Issue
- 0
- Publication date
- 1 March 2026
- Language
- EN